IP Library › Assignment 071566/0272
Patent Assignment
Reel/Frame 071566/0272

U.S. Patent Security Agreement

Recorded: 2025-06-13 Pages: 7
Assignor
BAUSCH HEALTH COMPANIES INC.
Executed: 2025-04-08
Assignee
JPMORGAN CHASE BANK, N.A.
10 SOUTH DEARBORN ST., CHICAGO, ILLINOIS, 60603
Covered Properties (5)
Methods for Effecting Regression of Tumor Mass and Size in a Metastasized Pancreatic Tumor
Patent: 7,795,205 →
Application: 11/099,370 →
Publication: US 2005/0233966
Teeth Whitening Composition and Methods
Patent: 8,075,875 →
Application: 11/598,206 →
Publication: US 2007/0128132
Photopolymerization Material for Gums Isolation
Patent: 8,334,328 →
Application: 12/525,890 →
Publication: US 2010/0152296
Formulations of Calcium and Phosphate for Oral Inflammation
Application: 14/945,865 →
Publication: US 2016/0175356
Compositions and Methods for Teeth Whitening
Patent: 9,655,829 →
Application: 15/006,943 →
Publication: US 2016/0136075
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Company Previously Recorded on Reel 024054 Frame 0599. Assignor(S) Hereby Confirms the Assignee Name Should Read as: Klox Technologies Inc. Nov 15, 2012
From: MARMARINOS, VASSILIOS; PASCHALAKIS, PASCHALIS
To: KLOX TECHNOLOGIES INC.
Reel/Frame 029309/0219 →
Assignment of Assignor's Interest Jan 15, 2015
From: CANYON PHARMACEUTICALS GROUP AG; CANYON PHARMACEUTICALS, INC.; CANYON PHARMACEUTICALS AG
To: MARATHON PHARMACEUTICALS, LLC
Reel/Frame 034723/0869 →
Assignment of Assignor's Interest Nov 19, 2015
From: INVADO PHARMACEUTICALS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 037089/0440 →
Assignment of Assignor's Interest Nov 19, 2015
From: WELDON, BARTHOLOMEW; KOBUS, EDWARD; DUMOULIN, SANDRYNE; BETANCOURT, AIMESTHER
To: INVADO PHARMACEUTICALS LLC
Reel/Frame 037089/0309 →
Assignment of Assignor's Interest Mar 15, 2016
From: KLOX TECHNOLOGIES INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 037979/0598 →
Assignment of Assignor's Interest Mar 15, 2016
From: LOUPIS, NIKOLAOS; PIERGALLINI, REMIGIO
To: KLOX TECHNOLOGIES INC.
Reel/Frame 038087/0482 →
Assignment of Assignor's Interest May 20, 2016
From: KLOX TECHNOLOGIES INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 038654/0239 →
Assignment of Assignor's Interest May 20, 2016
From: KLOX TECHNOLOGIES INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 038654/0505 →
Security Interest Jul 18, 2016
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039380/0385 →
Security Interest Jul 19, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043045/0959 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Change of Name Mar 15, 2019
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES, INC.
Reel/Frame 048609/0729 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Interest Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (Second Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Security Agreement (First Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Change of Name Jan 25, 2023
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 062493/0011 →
Security Interest Feb 13, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062670/0260 →
Security Interest Mar 15, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062983/0494 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →